Li-yun Cai

SLCO1B1 521T > C polymorphism associated with rosuvastatin-induced myotoxicity in Chinese coronary artery disease patients: a nested case–control study

Shi-long Zhong, W. Lai, Ju-e Liu, 2017, European Journal of Clinical Pharmacology.

Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for Patients Undergoing Percutaneous Coronary Intervention

Jiyan Chen, Shi-long Zhong, H. Lei, 2018, Clinical Pharmacokinetics.

UGT1A1 rs4148323 A Allele is Associated With Increased 2-Hydroxy Atorvastatin Formation and Higher Death Risk in Chinese Patients With Coronary Artery Disease

Shi-long Zhong, C. Deng, Min Qin, 2021, Frontiers in Pharmacology.

Simultaneous determination of atorvastatin and its metabolites in human plasma by UPLC-MS/MS

S. Zhong, Lan Tang, Zhijie Zheng, 2017 .

Impact of Plasma Exposure of Statins and Their Metabolites With Major Adverse Cardiovascular Events in Chinese Patients With Coronary Artery Disease

Shi-long Zhong, Zhi-ling Zhou, Qian Zhu, 2020, Frontiers in Pharmacology.

High Plasma Exposure of Statins Associated With Increased Risk of Contrast-Induced Acute Kidney Injury in Chinese Patients With Coronary Artery Disease

S. Zhong, Yong Liu, Bin Zhang, 2018, Front. Pharmacol..